参考文献/References:
[1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3):209-249.
[2] 中华医学会肿瘤学分会，中华医学会杂志社. 中华医学会胃癌临床诊疗指南(2021版). 中华医学杂志, 2022, 102(16):1169-1189.
[3] Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet, 2020, 396(10251):635-648.
[4] Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci, 2020, 21(11):4012.
[5] Yuan L, Xu ZY, Ruan SM, et al. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer, 2020, 19(1):96.
[6] Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell, 2019, 179(5):1033-1055.
[7] Cui L, Zhang X, Ye G, et al. Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer, 2013, 119(9):1618-1626.
[8] Shao J, Fang PH, He B, et al. Downregulated microRNA-133a in gastric juice as a clinicopathological biomarker for gastric cancer screening. Asian Pac J Cancer Prev, 2016, 17(5):2719-2722.
[9] Yu X, Luo L, Wu Y, et al. Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol, 2013, 30(1):365.
[10] Tang XH, Guo T, Gao XY, et al. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer, 2021, 20(1):99.
[11] Irmer B, Chandrabalan S, Maas L, et al. Extracellular vesicles in liquid biopsies as biomarkers for solid tumors. Cancers (Basel), 2023, 15(4):1307.
[12] Kagota S, Taniguchi K, Lee SW, et al. Analysis of extracellular vesicles in gastric juice from gastric cancer patients. Int J Mol Sci, 2019, 20(4):953.
[13] Skryabin GO, Vinokurova SV, Galetsky SA, et al. Isolation and characterization of extracellular vesicles from gastric juice. Cancers, 2022, 14(14):3314.
[14] Vinasco-Sandoval T, Moreira FC, F Vidal A, et al. Global analyses of expressed piwi-interacting RNAs in gastric cancer. Int J Mol Sci, 2020, 21(20):7656.
[15] Zhou X, Liu J, Meng A, et al. Gastric juice piR-1245: A promising prognostic biomarker for gastric cancer. J Clin Lab Anal, 2020, 34(4):e23131.
[16] Elimam H, Abdel Mageed SS, Hatawsh A, et al. Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay. Med Oncol, 2024, 41(9):218.
[17] Shao Y, Ye M, Jiang X, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer, 2014, 120(21):3320-3328.
[18] Shao Y, Ye M, Li Q, et al. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget, 2016, 7(25):37812-37824.
[19] Yang Y, Shao Y, Zhu M, et al. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer. Tumour Biol, 2016, 37(1):1183-1188.
[20] Yuan CL, Li H, Zhu L, et al. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. Neoplasma, 2016, 63(3):442-449.
[21] Pang Q, Ge J, Shao Y, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol, 2014, 35(6):5441-5447.
[22] Chen JS, Wang YF, Zhang XQ, et al. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Neoplasma, 2016, 63(2):223-230.
[23] Fei ZH, Yu XJ, Zhou M, et al. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer. Tumour Biol, 2016, 37(2):1983-1993.
[24] Watanabe Y, Kim HS, Castoro RJ, et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology, 2009, 136(7):2149-2158.
[25] Pizzi MP, Bartelli TF, Pelosof AG, et al. Identification of DNA mutations in gastric washes from gastric adenocarcinoma patients: Possible implications for liquid biopsies and patient follow-up. Int J Cancer, 2019, 145(4):1090-1098.
[26] Yamamoto H, Watanabe Y, Oikawa R, et al. BARHL2 methylation using gastric wash DNA or gastric juice exosomal DNA is a useful marker for early detection of gastric cancer in an H. pylori-Independent manner. Clin Transl Gastroenterol, 2016, 7(7):e184.
[27] Balonov I, Mattis M, Jarmusch S, et al. Metabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta-analysis. J Cancer Res Clin Oncol, 2024, 150(7):331.
[28] Zhou LY, Lin SR, Li Y, et al. The intrinsic fluorescence spectrum of dilute gastric juice as a novel diagnostic tool for gastric cancer. J Dig Dis, 2011, 12(4):279-285.
[29] Liu J, Lin S, Li Z, et al. Free amino acid profiling of gastric juice as a method for discovering potential biomarkers of early gastric cancer. Int J Clin Exp Pathol, 2018, 11(5):2323-2336.
[30] Arai J, Hayakawa Y, Tateno H, et al. The role of gastric mucins and mucin-related glycans in gastric cancers. Cancer Sci, 2024, 115(9):2853-2861.
[31]谷培,牛晓蕾,王立美,等.胃液粘蛋白表达水平对胃癌诊断价值分析.临床军医杂志,2024,52(7):709-711,714.
[32]Wu W, Yong WW, Chung MC. A simple biomarker scoring matrix for early gastric cancer detection. Proteomics,2016,16(22):2921-2930.
[33]Pan Y, Zheng Y, Yang J, et al. A new biomarker for the early diagnosis of gastric cancer: Gastric juice and serumderived SNCG. Future Oncol,2022,18(28):3179-3190.
[34]Hsu PI, Chen CH, Hsiao M, et al. Diagnosis of gastric malignancy using gastric juice alpha1antitrypsin. Cancer Epidemiol Biomarkers Prev,2010,19(2):405-411.
[35]Wu W, Juan WC, Liang CR, et al. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl,2012,6(3-4):152-162.
[36]Zhang Z, Wu H, Chong W, et al. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Cell Death Dis,2022,13(10):903.
[37]Virgilio E, Giarnieri E, Montagnini M, et al. Analyzing gastric lavage of gastric cancer patients: A prospective observational study on cytopathology and determination of intragastric CEA, CA19.9, CA72.4, and CA50. Acta Cytol,2016,60(2):161-166.